Media feature article
Academic article
-
Gry Sandvik Haaland; Ragnhild Sørum Falk; Oddbjørn Straume
et al. (2017). Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years. (external link)
-
Hanna Elisabet Dillekås; Monica Transeth; Martin Pilskog
et al. (2014). Differences in metastatic patterns in relation to time between primary surgery and first relapse from breast cancer suggest synchronized growth of dormant micrometastases. (external link)
-
Rita Grude Ladstein; Ingeborg M. Bachmann; Oddbjørn Straume
et al. (2010). Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma. (external link)
-
Cornelia Schuster; Lars A. Akslen; Tomasz Stokowy
et al. (2019). Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy. (external link)
-
Cornelia Schuster; Hans Petter Eikesdal; Hanne Eknes Puntervoll
et al. (2012). Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension. (external link)
-
Yanina Jeanne Leona Jansen; Elisa A. Lisette Rozeman; Robert Mason
et al. (2019). Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma. (external link)
-
Charalampos Tzoulis; Thomas Schwarzlmüller; Ivar Otto Gjerde
et al. (2015). Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report. (external link)
-
Martin Pilskog; Christian Beisland; Lars A. Akslen
et al. (2017). Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. (external link)
-
Jarle Arnes; Ingunn Marie Stefansson; Oddbjørn Straume
et al. (2012). Vascular proliferation is a prognostic factor in breast cancer. (external link)
-
Cornelia Schuster; Lars Andreas Akslen; Oddbjørn Straume
(2023). β2-adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma. (external link)
-
R Kumar; J Smeds; P Berggren
et al. (2001). A single nucleotide polymorphism in the 3' untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. (external link)
-
E Vuhahula; Oddbjørn Straume; Lars A. Akslen
(2000). Frequent loss of p16 protein expression and high proliferative activity (Ki-67) in malignant melanoma from black Africans. (external link)
-
Lars A. Akslen; Oddbjørn Straume; Stephanie Geisler
et al. (2011). Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer. (external link)
-
Oddbjørn Straume; Helga Salvesen; Lars A. Akslen
(1999). Angiogenesis is prognostically important in vertical growth phase melanomas. (external link)
-
Lars A. Akslen; Sabrina Angelini; Oddbjørn Straume
et al. (2005). BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. (external link)
-
George N. Naumov; Judah Folkman; Oddbjørn Straume
(2009). Tumor dormancy due to failure of angiogenesis: role of the microenvironment. (external link)
-
Oddbjørn Straume; L. Sviland; L.A. Akslen
(2000). Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. (external link)
-
Elin Aamdal; Kari Dolven Jacobsen; Oddbjørn Straume
et al. (2021). Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up. (external link)
-
Ingeborg M. Bachmann; Rita Grude Ladstein; Oddbjørn Straume
et al. (2008). Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas. (external link)
-
Oddbjørn Straume; Lars A. Akslen
(2004). Lymphatic vessel density and prognosis in cutaneous melanoma. (external link)
-
Lars A. Akslen; Hanne Eknes Puntervoll; Ingeborg M. Bachmann
et al. (2008). Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma. (external link)
-
Hanna Dillekås; Michael S. Rogers; Oddbjørn Straume
(2019). Are 90% of deaths from cancer caused by metastases?. (external link)
-
Cornelia Schuster; Lars A. Akslen; Oddbjørn Straume
(2016). Expression of Heat Shock Protein 27 in melanoma metastases is associated with overall response to bevacizumab monotherapy: Analyses of predictive markers in a clinical phase II study. (external link)
-
Oddbjørn Straume; Lars A. Akslen
(2005). Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma. (external link)
-
Oddbjørn Straume; Lars A. Akslen
(1999). Loss of nuclear expression of p16 protein correlates with increased tumor cell proliferation and poor patient outcome in patients with vertical growth phase melanoma. (Abstract no. P-487). (external link)
-
George N. Naumov; Monique B. Nilsson; Tina Cascone
et al. (2009). Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance. (external link)
-
Rita Grude Ladstein; Ingeborg M. Bachmann; Oddbjørn Straume
et al. (2012). Tumor necrosis is a prognostic factor in thick cutaneous melanoma. (external link)
-
Kristi Krüger; Laxmi Silwal-Pandit; Elisabeth Wik
et al. (2021). Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer. (external link)
-
Agnete Engelsen; Katarzyna Wnuk-Lipinska; Sébastien Bougnaud
et al. (2020). AXL is a driver of stemness in normal mammary gland and breast cancer. (external link)
-
GN Naumov; J Folkman; Oddbjørn Straume
(2008). Tumor dormancy due to failure of angiogenesis: role of the microenvironment. (external link)
-
Elin Aamdal; Eva Skovlund; Kari Dolven Jacobsen
et al. (2022). Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment. (external link)
-
George N. Naumov; Elise Bender; David Zurakowski
et al. (2006). A model of human tumor dormancy: An angiogenic switch from the nonangiogenic phenotype. (external link)
-
Dennis Karlheinz Völkl; Malte Mensching-Buhr; Thomas Sterr
et al. (2025). HIDE: Hierarchical cell-type deconvolution. (external link)
-
Martin Pilskog; Leif Bostad; Reidunn Jetne Edelmann
et al. (2018). Tumour cell expression of interleukin 6 receptor a is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. (external link)
-
Martin Pilskog; Gry Hilde Nilsen; Christian Beisland
et al. (2019). Elevated plasma interleukin 6 predicts poor response in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. (external link)
-
Ingeborg Bachmann; Oddbjørn Straume; Hanne Eknes Puntervoll
et al. (2005). Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. (external link)
-
Hanna Dillekås; Romano Demicheli; Ilaria Ardoino
et al. (2016). The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases. (external link)
-
Oddbjørn Straume; Takeshi Shimamura; Michael J.G. Lampa
et al. (2012). Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. (external link)
-
Ingeborg Margrethe Bachmann; Ole Johan Halvorsen; Karin Collett
et al. (2006). EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. (external link)
-
Romano Demicheli; Hanna Dillekås; Oddbjørn Straume
et al. (2019). Distant metastasis dynamics following subsequent surgeries after primary breast cancer removal. (external link)
-
Mikyung Kelly Seo; Oddbjørn Straume; Lars A. Akslen
et al. (2020). HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?. (external link)
-
Michael S. Rogers; Katherine Novak; David Zurakowski
et al. (2014). Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors. (external link)
-
Dag Hoem; Oddbjørn Straume; Heike Immervoll
et al. (2013). Vascular proliferation is associated with survival in pancreatic ductal adenocarcinoma. (external link)
-
Rita Grude Ladstein; Ingeborg M. Bachmann; Oddbjørn Straume
et al. (2014). Nestin expression is associated with aggressive cutaneous melanoma of the nodular type. (external link)
-
Rakel Brendsdal Forthun; Randi Hovland; Cornelia Schuster
et al. (2019). ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab. (external link)
-
Oddbjørn Straume; L.A. Akslen
(2001). Expression of vascular endothelial growth factor, its receptors (FLT-1. KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. (external link)
-
Rita Grude Ladstein; Ingeborg M. Bachmann; Oddbjørn Straume
et al. (2012). Prognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma. (external link)
Textbook
Conference lecture
Academic literature review
Conference poster
Doctoral thesis (PhD)
Academic book chapter
Letter to the editor
Lecture
Conference abstract
Case report
Non-fiction book chapter
See a complete overview of publications in Cristin.